Literature DB >> 7494011

Evaluation of mupirocin E-test for determination of isolate susceptibility: comparison with standard agar dilution techniques.

I N Simpson1, J Gisby, C P Hemingway, J Durodie, I Macpherson.   

Abstract

Mupirocin E-test strips have been evaluated for their ease of use and accuracy in determining the susceptibilities of 171 strains of Staphylococcus spp., Streptococcus spp., Haemophilus influenzae, and Moraxella catarrhalis. The susceptibility of each strain was determined on two occasions, using parallel E-test and agar dilution methodologies each time. To ensure similar precisions for statistical analyses, E-test MICs were rounded up to a standard twofold agar dilution scale. Clear, elliptical zones were obtained against Staphylococcus spp. M. catarrhalis also gave clear zones, but the scale intercept was often difficult to interpret because of the irregular shape of the inhibition zone. Poor growth sometimes resulted in less-distinct zones of inhibition against Streptococcus spp. and H. influenzae. Excellent correlation was observed between the the E-test and agar dilution against Staphylococcus spp. and H. influenzae, with > 95% of the E-test values falling within one log2 dilution of the corresponding agar MIC. The correlation was lower for Streptococcus spp. and M. catarrhalis, with 86 and 83%, respectively, of E-test results falling within one log2 dilution of the agar MIC. When E-test MICs did not agree exactly with the corresponding agar MIC against Staphylococcus spp. or Streptococcus spp., there was a tendency for the E-test to give a lower MIC. This bias has little effect upon individual MICs in staphylococci or in the generation of susceptibility interpretation errors ( < 1.5% overall), but it could reduce population geometric mean MICs by factors of 0.78 to 0.83. This effect was more marked for Streptococcus spp., reducing the population mean by a factor of 0.73 and resulting in 0.7% major and 8% very major errors. In contrast, the E-test tended to give higher MICs against M. catarrhalis, resulting in 7.3% major errors and increasing the population geometric mean MIC by a factor of 1.60.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494011      PMCID: PMC228389          DOI: 10.1128/jcm.33.9.2254-2259.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Mupirocin-resistant Staphylococcus aureus.

Authors:  B D Cookson; R W Lacey; W C Noble; D S Reeves; R Wise; R J Redhead
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Topical antibiotic treatment of impetigo with mupirocin.

Authors:  L D Eells; P M Mertz; Y Piovanetti; G M Pekoe; W H Eaglstein
Journal:  Arch Dermatol       Date:  1986-11

4.  A multicenter survey of resistance in The Netherlands using the Etest.

Authors:  B van Klingeren; E E Stobberingh; D M MacLaren; P I Schmitz; M Murmans; T Smeets; M Dessens
Journal:  Diagn Microbiol Infect Dis       Date:  1994-07       Impact factor: 2.803

5.  Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures.

Authors:  R P Wenzel; M D Nettleman; R N Jones; M A Pfaller
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

6.  Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

Authors:  B N Doebbeling; D L Breneman; H C Neu; R Aly; B G Yangco; H P Holley; R J Marsh; M A Pfaller; J E McGowan; B E Scully
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

7.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.

Authors:  J Goldfarb; D Crenshaw; J O'Horo; E Lemon; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

9.  The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage.

Authors:  R J Redhead; Y J Lamb; R B Rowsell
Journal:  Br J Clin Pract       Date:  1991

10.  Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test.

Authors:  J H Jorgensen; A W Howell; L A Maher
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  2 in total

1.  Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains.

Authors:  Shigeru Fujimura; Yutaka Tokue; Akira Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Comparative Analysis of Gradient Diffusion and Disk Diffusion with Agar Dilution for Susceptibility Testing of Elizabethkingia anophelis.

Authors:  Chien-Tung Chiu; Chung-Hsu Lai; Yi-Han Huang; Chih-Hui Yang; Jiun-Nong Lin
Journal:  Antibiotics (Basel)       Date:  2021-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.